WntResearch: As announced September 4.th new research findings show that Foxy-5 counteracts spread of prostate cancer cells
WntResearch's Chief Scientific Officer, Professor Tommy Andersson, together with his research team, and in collaboration with Professor Anders Bjartell's research group, both at Lund University, has published a scientific article in the journal PLOS ONE. The article describes how Foxy-5 inhibits spread of prostate cancer cells in a model where Foxy-5 treatment is not commenced until after a primary tumor has been established in the prostate.The study results show that administration of Foxy-5, although initiated after primary tumors have been established, strongly inhibits the spread of